INC Research Strengthens Oncology Division with Proven Leadership
07 August 2008
INC Research is a theraputically-focused contract ressearch organization (CRO) with a process for delivering reliable results, who have recently announced Nick Kenny, Ph.D. as the senior vice president of oncology. Dr Kenny has proven his ability to drive the overall strategy and direction for this significant division for the CRO. John Potthoff, COO of INC research said, "Nick was the obvious choice to step into this senior management role in oncology. Not only does he have impeccable therapeutic expertise, but he has been instrumental in fine tuning the methodologies that we use today in our trusted process for delivering high quality clinical results that meet or exceed customer expectations."
Dr Kenny has 25 years of research, development and international project integration experience in the CRO and academic segments. Prior to INC Research, he held various management positions at CROs where he established the strategic direction of clinical programs, as well as global oversight of project management, clinical monitoring and programs, as well as global oversight of project management, clinical monitoring and regulatory staff. Prior to his move to industry, Dr. Kenny spent 15 years in endocrinology and cell biology research and teaching in the UK, Canada, and the United States where he was assistant professor in the College of Medicine at the University of Vermont. Over the past ten years, Dr. Kenny’s drug development expertise has been primarily focused upon oncology clinical development. He is continually sought after as a subject matter expert to represent both CRO and oncology perspectives by industry publications and conferences.
